The role of the adipocyte-derived factor visfatin in metabolism remains controversial, although some pancreatic beta-cell-specific effects have been reported. This study investigated the effects of visfatin upon insulin secretion, insulin receptor activation and mRNA expression of key diabetes-related genes in clonal mouse pancreatic beta-cells. beta-TC6 cells were cultured in RPMI 1640 and were subsequently treated with recombinant visfatin. One-hour static insulin secretion was measured by ELISA. Phospho-specific ELISA and western blotting were used to detect insulin receptor activation. Real-time SYBR Green PCR array technology was used to measure the expression of 84 diabetes-related genes in both treatment and control cells. Incubation...
In tro duc ti on Visfatin was previously known as the pre-β cell colony-enhancing factor (1). In 200...
Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that...
Visfatin has shown to be increased in type 2 diabetes but to be unrelated to insulin sensitivity. We...
The role of the adipocyte-derived factor visfatin in metabolism remains controversial, although some...
The role of the adipocyte-derived factor visfatin in metabolism remains controversial, although some...
Tumor necrosis factor α (TNFα) is a well-known mediator of inflammation in the context of obesity in...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Adipose tissue secreted proteins (adipokines) have been proposed to form a link between obesity and ...
Visfatin was originally described as an adipokine with insulin mimetic effects. Recently, it was fou...
Background/Aims: Visfatin is a known adipokine which may improve insulin resistance in obesity and h...
Visfatin is a cytokine hormone and an enzyme involved in metabolic (obesity, type II diabetes) and i...
Interferon-γ (IFN-γ) plays an important role in apoptosis and was shown to increase the risk of diab...
It is clear that sub-clinical inflammation is a key factor that triggers type 2 diabetes mellitus (T...
In tro duc ti on Visfatin was previously known as the pre-β cell colony-enhancing factor (1). In 200...
Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that...
Visfatin has shown to be increased in type 2 diabetes but to be unrelated to insulin sensitivity. We...
The role of the adipocyte-derived factor visfatin in metabolism remains controversial, although some...
The role of the adipocyte-derived factor visfatin in metabolism remains controversial, although some...
Tumor necrosis factor α (TNFα) is a well-known mediator of inflammation in the context of obesity in...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipos...
Adipose tissue secreted proteins (adipokines) have been proposed to form a link between obesity and ...
Visfatin was originally described as an adipokine with insulin mimetic effects. Recently, it was fou...
Background/Aims: Visfatin is a known adipokine which may improve insulin resistance in obesity and h...
Visfatin is a cytokine hormone and an enzyme involved in metabolic (obesity, type II diabetes) and i...
Interferon-γ (IFN-γ) plays an important role in apoptosis and was shown to increase the risk of diab...
It is clear that sub-clinical inflammation is a key factor that triggers type 2 diabetes mellitus (T...
In tro duc ti on Visfatin was previously known as the pre-β cell colony-enhancing factor (1). In 200...
Visfatin (also known as pre-B cell colony-enhancing factor) is a newly discovered adipocytokine that...
Visfatin has shown to be increased in type 2 diabetes but to be unrelated to insulin sensitivity. We...